chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme Fatigue; headache; Sore Arm; swollen lymph nodes in the arm pit where she received the injection; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 22Dec2021 18:45 (Lot number: 330258D) at the age of 39 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (First Dose, Lot: ER8734, her glands under her chin were swollen on one side after one of the first or second vaccines), administration date: 21Apr2021, when the patient was 38 years old, for COVID-19 vaccination, reaction(s): "glands under her chin were swollen on one side after"; Bnt162b2 (Second Dose, Lot: EW0170), administration date: 12May2021, when the patient was 38 years old, for COVID-19 vaccination, reaction(s): "glands under her chin were swollen on one side after". The following information was reported: IMMUNISATION (non-serious) with onset 22Dec2021 18:45, outcome "unknown", described as "Booster"; FATIGUE (non-serious) with onset 23Dec2021 08:00, outcome "recovered" (27Dec2021), described as "Extreme Fatigue"; HEADACHE (non-serious) with onset 23Dec2021 08:00, outcome "recovered" (26Dec2021), described as "headache"; PAIN IN EXTREMITY (non-serious) with onset 23Dec2021 08:00, outcome "recovered" (25Dec2021), described as "Sore Arm"; LYMPHADENOPATHY (non-serious) with onset 23Dec2021 08:00, outcome "recovered" (26Dec2021), described as "swollen lymph nodes in the arm pit where she received the injection". Therapeutic measures were taken as a result of fatigue, headache, pain in extremity, lymphadenopathy.  Additional information: The patient stated that she wanted to report the side effects she experienced with the Booster Dose. The patient stated that most were standard symptoms and they lasted a solid 4 days after booster, some 4.5 to 5 days. The patient stated that they were extreme fatigue, headache, swollen lymph nodes in the arm pit where she received the injection, and sore arm. The patient stated that she received the Booster Dose on Wednesday evening at 6:45 p.m. and she started having the side effect when she woke up the next morning at 8:00 a.m. on Thursday 23Dec2021. The patient stated that she had to call off work and take multiple naps each day. The patient stated that she took Acetaminophen and when that didn't start to help she also took Aspirin and at different points she took Tylenol and Ibuprofen. Acetaminophen 1000mg; 2 500mg. The patient stated that it did help but the Tylenol and Ibuprofen were working better.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 70-year-old female patient who received SHINGRIX for prophylaxis. Concomitant products included ENTYVIO. On 5th December 2018, the patient received SHINGRIX. On 5th December 2018, 1 hr after receiving SHINGRIX, the patient experienced fever, general body pain and influenza-like symptoms. On an unknown date, the outcome of the fever, general body pain and influenza-like symptoms were recovered/resolved. It was unknown if the reporter considered the fever, general body pain and influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The batch number for SHINGRIX was not provided. On 13th November 2018, the patient received an infusion of ENTYVIO at the clinic infusion center. The patient was administered SHINGRIX at an outside facility (local pharmacy) and was not administered by the reporter. The patient experienced fever that began 1 hour after vaccination and lasted for 2 hours. Less than a day after receiving vaccination, the patient experienced body aches and flu-like symptoms which lasted for 1 week. The patient did not experience any injection site reactions. Medications used by the patient to treat their adverse symptoms were not reported. The address of the pharmacy where SHINGRIX was administered was not provided.
pt recvd vax & 24 hrs p/vax exp swollen, sore, red, hot, pruritic rt deltoid; pt placed cold compresses on rt deltoid site; pt states that the swelling, redness, soreness, & hot feeling subsided w/in 5 days;
"Right after the vaccine I had a tingling feeling in  my finger tips" hasn't gotten worse.  Still there a little bit." 8:15 PM SpO2 99%, HR 66, BP 125/86
About 8 hours after the injection, I experienced extreme chills with excessive shaking.  My hips hurt when I walked. I went to bed feeling that way and then woke up at 3am in a heavy sweat. I woke up repeatedly for the rest of the night with aches and sweating. I also had a bad headache. I did have a few drinks during the evening which likely contributed significantly to the headache. It?s been 12 hours since the start of the reaction, and I feel significantly better but unsure if I have fully recovered.
Member felt nauseous and vomited.  Felt better within 30 minute obs, vitals checked
Patient was vaccinated 10/03/17 and had been doing well. Patient presented 10/17/17 with father to clinic. The school called stating that she had blood in urine. Urine dipstick done in office and labs and urine sent out for testing. Patient had critical lab results: PLATELET COUNT [L] 7 Thousand/uL. Verified by repeat analysis. Pt is currently hospitalized. No official correlation identified at this time with vaccine administration and symptoms but with the close proximity of events- report was filed.
Broke out with a rash/hives. Redness, itchy. Broke our on arms, legs and face.
We gave 3 doses of expired Moderna Covid-19 vaccine/Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We gave 3 doses of expired Moderna Covid-19 vaccine/Dose administered after 30-day Use By Date or after manufacturer date of expiry) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 14-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (We gave 3 doses of expired Moderna Covid-19 vaccine/Dose administered after 30-day Use By Date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (We gave 3 doses of expired Moderna Covid-19 vaccine/Dose administered after 30-day Use By Date or after manufacturer date of expiry) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information was not provided. It was reported that patient was administered 1/2 dose of 2nd booster. The vial was initially stored in the refrigerator on 13-Apr-2022. It was stated that the vial did not undergo any temperature excursions. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2022: Follow up received and contains no new information
Patient was given a Moderna and not a PFizer.  Patient made aware of the incident at the time.  Explained that the dose doesn't need to be repeated and the side effects to watch for the patient voiced understanding.
Pfizer vaccine was diluted with NS 0.9% Bacteriostatic which is not recommended for use with this vaccines. Reported to Pfizer and CDC. As per recommendation from CDC, affected dose should be repeated. Pt was notified and all questions answered. Pt was scheduled to repeat dose on 9/15/21, pt cancelled appt.
7/31/00 had a fever (max 104F); 8/1/00-8/2/00 had on and off tactile fever; 8/3/00 at office temp was 100.2F(R) and a rash on face and trunk; 8/8/00 had maculopapular rash (decreasing) on trunk, post-auricular area; 8/10/00 no rash, resolved.
Patient called pharmacy 3/12/18 to report a hard red lump at injection site that felt warm to the touch. She treated with ice. She sought medical attention on 3/13/2018 where she was diagnosed with injection site infection and sinus infection and received two antibiotics: AUGMENTIN 875 with a booster of amoxicillin 875mg.
I had increasingly extreme fatigue, indigestion and chest discomfort that went on for four to six weeks, I called my PCD and they sent me to the ER and they did lots and lots of tests and they said I was fine. I just started feeling better recently. DR was the ER DR that I saw. June 22, 2021 I went to the ER.
My first shot was 1/14/21 with a very sore arm for one week.  Second dose lot#024M20A on 2/11/21  about 40 minutes after shot I noticed in my car the slight whining on my exhale.  one day post with cold sweats and moderate pain in arm, across bilateral shoulders, and upper back. Then a dry cough started at my exhale, intermittent.  I still have it.  I tired an inhaler that made my blood pressure high so I stopped after a day.
This spontaneous report as received from a other health professional refers to a 18 year old patient. On 22-JUL-2014 the patient was vaccinated with MMR II (lot # H011885, expiration date: 25-JUN-2014) 0.5 ml, subcutaneously, which was expired. This is one of several reports received from the same source. Additional information has been requested.
10:18 am pt reported feeling dizzy and developing a headache. PT was monitored for a period of time, around 10:55 pt complained of tickle in throat and feeling drunk.  At 11:00am pt complained of tingling in hands and feet,  had difficulty standing  without swaying, her voice became raspy, she complained of some tightness in the throat. At this point Epinephrine 0.3 mg (epi-pen) was given. Patient was transferred to the hospital via ambulance.
Seizure affecting arms and legs, patient became very pale. Seizure lasted approx 15 sec.
Lower back became very stiff and hurt when moved.  Could not take a full breath without pain in back.
bone pain in my left hip bone and down my femur to my knee which lasted 3 days; I was limping; 2nd dose-chills; sweating; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Mar2021 13:45 (Batch/Lot number: unknown) at the age of 40 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies: penicillin" (unspecified if ongoing). Concomitant medication(s) included: LEXAPRO; ZYRTEC [CETIRIZINE HYDROCHLORIDE]. Past drug history included: Diflucan, reaction(s): "known allergies: Difulcan"; Bactrim, reaction(s): "known allergies: Bactrim". Vaccination history included: Bnt162b2 (Dose 1, single; lot: unknown), reaction(s): "weird sensation in my brain", "Chills", "Headache", "Accelerated heart rate", "high  blood pressure", "night sweats". The following information was reported: BONE PAIN (non-serious) with onset Mar2021, outcome "recovered", described as "bone pain in my left hip bone and down my femur to my knee which lasted 3 days"; GAIT DISTURBANCE (non-serious) with onset Mar2021, outcome "recovered", described as "I was limping"; CHILLS (non-serious) with onset Mar2021, outcome "recovered", described as "2nd dose-chills"; HYPERHIDROSIS (non-serious) with onset Mar2021, outcome "recovered", described as "sweating". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of bone pain, gait disturbance, chills, hyperhidrosis.  Additional information: Bnt162b2 vaccine administration time given as 1:45 PM. Patient did not received other vaccine in four weeks. Patient received other medications in two weeks as 15 mg lexapro, zyrtec, multivitamin. It was unknown if patient had covid prior vaccination. Patient did not tested for covid post vaccination. Facility type vaccine was Pharmacy or Drug Store.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Nausea (dry heave), Light-headedness, slight hand tremors, increased respirations, pain and warmth at injection site, tiredness, slight facial skin tightening, tingling of hands and feet
Within 15 minutes of administration pt started complaining of itching. Itching radiated from vaccine site across shoulders to other arm. Pt developed redness in both arms. 50mg of diphenhydramine was administered IM in opposite arm.  BP remained normal at all checks, HR remained normal. Pt denied any difficulty breathing, swelling or itching of throat or mouth. Pt was released after 40 minutes with instructions to follow up with Urgent care facility (pt has no PCP in the area) and was counseled to watch for return of symptoms and to seek emergency care if they returned
body aches for 2 days , chills for 2 days , fever that was 101.6 for 2 days , head ache for 6 days, gums(top) swollen inflamed for 6 days
Thursday, 11/25/2021 Achy arm at shot site, but not as bad as 1st shot Small raised firm bump at shot site Mild cramps in morning Chills morning Progressive high temperature 102 by 5:00pm  Friday, 11/25/2021 Morning - mild cramps, temperature back to normal Under arm pit - achy Shot site - still achy and with heart shaped pink puffiness and hard at shot site 2:00pm - temperature 102 6:00pm - temperature normal
Fever, chills, edema, redness, warm to touch. 11cm x 12cm firm shoulder to above elbow.
3FEB93 pt mom called to report that lt arm was red extending to under arm pit t103-goint to MD; 4FEB94 mom reports MD did not feel react was unusual; prev noc t104; pt taken to ER-CXR done neg;
Patient briefly lost consciousness for 15-20 seconds and became incontinent.  Regained consciousness and did not lose it again while at our location.  Was taken to the ER department by emergency services.
Flu symptoms: Vomiting 10/19/03 2:30PM - 10/19/03 8:30 PM Fever measured 10/19/03 @8:00PM about 100 Diarhhea 10/20/03 8:00 AM - 10/20/03 4:00 PM Muscle soreness & fatigue 10/19/03 2:00PM -    10/22/03
Site: Bruising at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Additional Details: The Pfizer vaccination was reconstituted according to the CDC guidelines and using aseptic technique. After the pfizer vaccine was administered into the left arm deltoid muscle, the surrounding tissue began to swell and form a raised and hardened lump about one inch in diameter.  The lump was about 3 degrees warmer than the surrounding tissue. The patient was instructed to move her arm to increase blood flow to the area, wait in the observation area for 30 minutes, and inform her physician.
Sweats beginning about 11pm, 10 hours after injection and lasting all night.  Low grade headache beginning 11pm, still continuing Aches, lethargy
Mom called the office on 7/9/15 stating shortly after arriving home child "seemed lethargic and lazy". Mom reported he did not eat dinner and went to bed at 6:30pm. Mom checked on him at 9:30pm and found he had possible two separate events of vomiting, felt clammy to the touch. Mom did not check his temp. Child is home with parent today and doing well no events of vomiting.
Patient hospitalized for Dichorionic diamniotic twin pregnancy in third trimester, had Cesarean section and bilateral tubal ligation within 6 weeks of receiving covid vaccination.
No Adverse Event; received Bivalent Moderna COVID-19 vaccine instead of Monovalent first dose; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (received Bivalent Moderna COVID-19 vaccine instead of Monovalent first dose) and NO ADVERSE EVENT (No Adverse Event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 214K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Apr-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. On 14-Apr-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (received Bivalent Moderna COVID-19 vaccine instead of Monovalent first dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, WRONG PRODUCT ADMINISTERED (received Bivalent Moderna COVID-19 vaccine instead of Monovalent first dose) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (received Bivalent Moderna COVID-19 vaccine instead of Monovalent first dose).    No concomitant medication were reported.  Reporter did not have patient information and was not a hundred percent sure about the date of the event. No treatment information was provided by the reporter.
I HAVE FEVER, MUSCLE PAIN ALL OVER-HEADACHES,,PAIN JOINTS NOTHING TAST GOOD PLEASE HAVE V-SAFE START TO CHECK ON. ME, ,AFTER THE FIRST VACCINE BUT NEVER CALLED SINCE I HAD THE SECOND VACCINE ON2/8/21NONE
Expired Bexsero administered; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number A2X3Y, expiry date 28-FEB-2023) for prophylaxis.   Concomitant products included Men B NVS (Bexsero).   On 22-MAR-2023, the patient received the 2nd dose of Bexsero. On 22-MAR-2023, an unknown time after receiving Bexsero, the patient experienced expired vaccine used (Verbatim: Expired Bexsero administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 23-MAR-2023 On 23rd March 2023, the physician reported that the patient received the 2nd dose of Bexsero and the dose was already expired.  The first dose was received on 22nd February 2023. Reporter consented to follow up. The patient received a Bexsero vaccine which was already expired, which led to expired vaccine used.
Initial report received from the nurse on 05 Apr 2010: This patient was inadvertently vaccinated with expired FLUVIRIN (batch no: 1013284P, exp date: Mar2010), 0.5 ml, intramuscular on 05 Apr 2010. On 05 Apr 2010, this patient had not presented with adverse event. The outcome of the event was reported as unknown.
Pt fainted in the parking lot p/receiving MMR; States has had litle to eat today, temp outside 94; Taken to clinic&fainted again; BP 90/60 legs elevated p/lying down&cool compresses to head&neck; Abrasion cleaned & dressed by MD; BP 110/70;
- Pronounced fatigue and full-body muscular soreness. - Persistent headache. - Felt both clammy and feverish, though temperature measured low: high 96s and low 97s. - Trouble sleeping.  Symptoms started within 12-24 hours of injection, peaked within 36-48 hours of injection, and fully subsided within 72-96 hours of injection.  Self-treated with periodic ibuprofen 200mg approximately 8 times, which provided noticeable pain relief.
Fever to 100 next day, muscle aches on Day2, Day 2 after shot with full body diffuse, erythematous, fine papular rash, itchy.
Prior to receiving the vaccine I didn?t have a menstrual cycle. Now I have one nonstop.
Pt presented to the office 11/1/18 complaining of left sided facial swelling. Started 10/30/18 in the am and she believes related to vaccines she received 10/29/18. Was sent to the Urgent care and was dx with right sided Bells Palsy.
Pt felt "near syncope" event, with a feeling like she was going to vomit.  The sensations relived themselves with several minutes of observation from the EMTs on site.
Pt exp abdominal cramps & diarrhea, arthralgia, & h/a;
Initial unsolicited report received from consumer on 28 October 2016. This case involves 77-year-old male patient who was vaccinated with a dose of Fluzone HD (batch number, expiry date, and site of administration was not reported) intramuscularly on 20 October 2016. Illness at time of vaccination reported as none and pre-existing physician diagnosed allergies, birth defects, a medical condition was reported as allergic to contrast dye. Concomitant medication was not reported. On 20 October 2016, 1.5 hour following the vaccination, patient began having difficulty breathing, gasping for air and in next morning he was still having breathing difficulties and went to the emergency room. On an unspecified date following vaccination patient reported that similar reaction many years ago when patient had dye injected for a test and was allergic to a component of it. On an unspecified date patient was hospitalized and released after 2 days. Lab data reported as echocardiogram was negative. It was reported that stress test scheduled for 31 October 2016. Corrective treatment was not reported. Patient was not recovered from events. It was reported that still having breathing difficulties, but not as severe. List of documents held by sender: none. Sender's Comments: INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE contains only a limited quantity of egg protein, this protein can induce immediate hypersensitivity reactions among persons who have severe egg allergy. Time to onset is compatible with the role of the vaccine. However investigation result to identify the culprit antigen and any other etiology would be helpful to assess this case further.
Light headed, chills, fever and blurred vision about 30-45 minutes after vaccination. He is with Safety Officer/EMT in seafood plant. Has been relocated to his bunkroom to rest and has safety office checking on him every 15 minutes. If not improving within two to three hours the seafood plant will call 911 for ambulance or take him to the hospital ED for evaluation.
Pt vaccinated with smallpox vaccine 1/29/03.  (Pt is vaccinee) developed macular-papular rash 5 days ago 2/5/03. Also immunized with several vaccine on same day. The progress note per description of rash. Rx Allegra 180mg and Moisturizer cream with stroid. Rash fading. Received Anthrax #3 2/3/03.
Muscles started convulsing; feeling dizzy; Vision started going in and out; Fell over; legs were weaker than ever; This is a spontaneous report from a non-contactable consumer (patient). A 31-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot Number: Er8733) as single dose for COVID-19 immunisation. Medical history included COVID: prior to vaccination. Concomitant medications were not reported. The patient had no known allergies. The patient had no other vaccine in four weeks. 3 hours after shot, the patient started feeling dizzy. Stood up then vision started going in and out. Fell over. Muscles started convulsing and legs were weaker than ever. The patient had no treatment for the events. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.